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Recent analyses of sequence and microarray data have suggested that alternative splicing 
plays a major role in the generation of proteomic and functional diversity in metazoan 
organisms. Efforts are now being directed at establishing the full repertoire of functionally 
relevant transcript variants generated by alternative splicing, the specific roles of such 
variants in normal and disease physiology, and how alternative splicing is coordinated on 
a global level to achieve cell- and tissue-specific functions. Recent progress in these areas 
is summarized in this review.One of the most remarkable observations stemming 
from the sequencing of genomes of diverse species is 
that the number of protein-coding genes in an organ-
ism does not correlate with its overall cellular complex-
ity. For example, Drosophila melanogaster has fewer 
protein-coding genes than the nematode Caenorhab-
ditis elegans (?14,000 versus ?19,000). Meanwhile, 
mammalian species have similar numbers of protein-
coding genes as Arabidopsis thaliana (?20,000–
25,000) and only four times the number found in the 
budding yeast Saccharomyces cerevisiae (?6,000). 
These observations indicate that mechanisms acting 
to regulate and diversify gene functions must have 
played a major role in the evolution of specialized cell 
types and activities that are typically associated with 
complex metazoans. Alternative splicing (AS), the 
process by which the exons of primary transcripts 
(pre-mRNAs) from genes can be spliced in different 
arrangements to produce structurally and functionally 
distinct mRNA and protein variants, may be one of the 
most extensively used mechanisms that accounts for 
the greater macromolecular and cellular complexity of 
higher eukaryotic organisms.
AS has numerous critical roles in metazoan organ-
isms (Black, 2003; Matlin et al., 2005). Despite many 
focused studies on the functions and mechanisms of 
AS that are associated with specific transcripts, high-
throughput experimental approaches for systemati-
cally elucidating the roles of AS events are only now 
beginning to be used. Considerable effort has been 
directed at the genome-wide identification of AS 
events in different cell and tissue types and under dif-
ferent conditions in order to establish the extent of 
functionally relevant AS events. Initial analyses of the 
resulting data sets are revealing important global reg-
ulatory features of AS.Technologies for the Global Analysis of AS
The availability of sequenced genomes and large data-
bases of sequenced transcripts, primarily comprising 
expressed sequence tags (ESTs) and smaller numbers 
of cDNA sequences, has provided a rich source of infor-
mation for the identification and analysis of AS events. 
EST and cDNA sequences can be aligned to genomic 
sequences using programs that search for conserved 
splice-site consensus sequences adjacent to the gaps 
created by intron sequences between the aligned exons. 
Contigs of genomic exons extracted in this manner are 
realigned to the corresponding ESTs and cDNAs such 
that clusters of aligned transcripts with or without mid-
dle exon alignments (indicative of an AS event) can be 
systematically identified. Large databases of AS events 
mined in this manner have been established for several 
species, including human, mouse, and rat (Modrek and 
Lee, 2002; Lee et al., 2003; Thanaraj et al., 2004; Zheng 
et al., 2005). However, a major limitation of AS analyses 
employing transcript sequence data is that EST cover-
age is typically biased toward the 3′ and 5′ ends of tran-
scripts, and in general there are insufficient numbers of 
sequenced transcripts to infer the frequency with which 
specific alternative exons are included or skipped in a 
given cell or tissue source or under particular experimen-
tal conditions (Johnson et al., 2003; Pan et al., 2004).
Some of the limitations inherent in the analysis of 
EST/cDNA have been overcome by the development of 
custom microarrays and computational tools, as well 
as differential hybridization techniques, that permit the 
large-scale profiling of AS (Yeakley et al., 2002; John-
son et al., 2003; Wang et al., 2003; Le et al., 2004; Pan 
et al., 2004; Stolc et al., 2004; Watahiki et al., 2004; 
Blanchette et al., 2005; Ule et al., 2005; Shai et al., 
2006; Sugnet et al., 2006). Several of the AS micro-
arrays that have been described contain thousands Cell 126, July 14, 2006 ©2006 Elsevier Inc. 37
of sets of anchored oligonucleotide probes on glass 
slides, with each set typically combining probes that 
are specific to individual exons and/or splice-junction 
sequences formed by inclusion or skipping of exons 
(Figure 1). This type of format has permitted the dis-
covery of new AS events not previously detected in 
cDNA or EST sequences (Johnson et al., 2003) and 
the large-scale detection of cell- and tissue-specific 
AS events involving exons that were initially identified 
using EST/cDNA sequence data (Pan et al., 2004). 
More recently, this microarray format has facilitated 
the global analysis of alternative exons regulated by 
specific splicing factors (Blanchette et al., 2005; Ule 
et al., 2005) and has led to the discovery of sequence 
motifs that correlate with tissue-specific AS (Sugnet 
et al., 2006). Another microarray format employing a 
fiber-optic-based system for the detection of specific 
splice variants has been described, and this approach 
has been used to monitor splice variants in differ-
ent transformed cell lines and tumors (Yeakley et al., 
2002; Li et al., 2006; Zhang et al., 2006).
Figure 1. Microarray Profiling of AS
(A) Cassette-type AS events, which consist of an alternative exon “A” 
(blue box) flanked by intron sequences and constitutively spliced ex-
ons “C1” and “C2” (yellow boxes), represent the most common type 
of regulated AS event and have been the most extensively analyzed 
by sequence- and microarray-based methods (see also Figure 2). In 
the example shown, a set of six probes, three targeted to exons (C1, 
A, and C2 probes) and three to splice-junction sequences (C1-A, A-
C2, and C1-C2), permits the quantitative profiling of a cassette alter-
native exon between two different tissue types (tissues X and Y). In the 
example shown, the cassette alternative exon is skipped in tissue X 
and included in tissue Y. Adapted from Pan et al. (2004).
(B) Hypothetical hybridization pattern obtained from microarray profil-
ing of AS using Cy3-labeled tissue X cDNA (green) and Cy5-labeled 
tissue Y cDNA (red). Green and red spots indicate detection of sig-
nals from probes hybridized to the labeled cDNA from tissues X and 
Y, respectively. Yellow spots indicate detection of signal from exons 
or splice junctions that are expressed in both tissues X and Y. Data 
processed using a suitable algorithm from this microarray format can 
permit the accurate prediction of AS levels for thousands of cassette-
type alternative exons (Shai et al., 2006).38 Cell 126, July 14, 2006 ©2006 Elsevier Inc.Insights into the Global Complexity of AS
Based on systematic analyses of ESTs and cDNAs, 
especially from mammalian species, it is apparent that 
the most common type of AS, accounting for at least 
one-third of known AS events, involves cassette-type 
alternative exons. These exons, which are either skipped 
or included in the final message, are flanked by intron 
sequences (Figure 1 and Figure 2). Alternative selection 
of 5′ or 3′ splice sites within exon sequences are also 
frequent, together accounting for at least one-quar-
ter of the known AS events (Figure 2). This type of AS 
is capable of introducing subtle changes into coding 
sequences, differing by as little as a single codon. For 
example, approximately 30% of human genes contain 
NAGNAG sequences at the 3′ ends of introns, which 
have the potential to act as tandem splice-site accep-
tors (Hiller et al., 2004). However, it is not clear to what 
extent such subtle variants are functionally significant, 
and a recent analysis suggests that a large fraction may 
arise as a consequence of stochastic binding of the spli-
ceosome at neighboring splice sites (Chern et al., 2006) 
Figure 2. AS Events in Metazoan Transcripts
Types of AS that are responsible for the generation of function-
ally distinct transcripts are depicted. Blue boxes indicate alter-
native exons.
(see below). Other types of AS events include retained 
introns (Ohler et al., 2005) and exons that are spliced in 
a mutually exclusive fashion (Figure 2).
In addition to the AS mechanisms mentioned above, 
the exon composition of transcripts is often altered by 
differential selection of transcription initiation and 3′ 
end processing/termination sites (Figure 2), and these 
events can impact on adjacent or distal AS events in the 
same transcript (Zavolan et al., 2003; Kornblihtt, 2005). 
In several studies, it has been shown that transcription 
factors acting at the level of initiation and elongation can 
impact splice-site selection (Kornblihtt, 2006). In par-
ticular, factors resulting in reduced rates of RNA poly-
merase II (Pol II) elongation can increase the inclusion of 
alternative exons. One model that has been proposed to 
explain this effect is that reducing the rate of Pol II elon-
gation kinetically favors the recognition of relatively weak 
splicing signals surrounding an alternative exon over the 
inherently stronger splicing signals that otherwise favor 
splicing of the neighboring upstream and downstream 
constitutive exons, resulting in skipping of the alternative 
exon (Kornblihtt, 2006).
It is worth noting that for each type of AS event men-
tioned above, a distinction can be made between mech-
anisms controlling splice-site selection involving the 
binding of regulatory factors and mechanisms that may 
operate in a stochastic manner. For example, the selec-
tion of mutually exclusive exons 2 and 3 in the α-tropo-
myosin pre-mRNA involves the repression of exon 3 by 
trans-acting regulatory factors in smooth muscle cells 
(Gromak et al., 2003), whereas a stochastic process 
involving competing base-pairing interactions between 
intron sequences appears to play an important role in 
selection of mutually exclusive alternative exons in the 
Dscam gene of Drosophila (Graveley, 2005). Remark-
ably, this gene, which functions in both axon guidance 
and immune defense (Schmucker et al., 2000; Watson et 
al., 2005; Chen et al., 2006), has the potential to encode 
over 38,000 different splice variants, primarily via tan-
dem arrays of mutually exclusive alternative exons, many 
of which overlap the coding regions for immunoglobulin-
like domains. Finally, it should also be kept in mind that 
each of the types of AS summarized above and shown in 
Figure 2 can occur within both translated and untrans-
lated regions (UTRs) of transcripts.
Consistent with the evidence that RNA Pol II can influ-
ence splice-site selection, experimental work indicates 
that most splicing events, as well as other steps in pre-
mRNA processing, occur on pre-mRNA as it emerges 
from Pol II (Bentley, 2005). Recent evidence further indi-
cates that the exons of nascent transcripts can be “teth-
ered” to Pol II during pre-mRNA processing (Dye et al., 
2006). In addition to potentially participating in AS, teth-
ering of nascent exons to Pol II, together with the forma-
tion of networks of interactions across introns and exons 
(see below), may help to ensure order in the splicing pro-
cess such that correct pairs of splice sites are united, 
even when separated by introns that are tens of thou-sands of bases in length (Ibrahim el et al., 2005; Dye et 
al., 2006). Downstream exons are rarely, if ever, inserted 
between upstream exons, and trans-splicing, although 
common in nematodes and trypanosomes, also rarely 
occurs in most metazoan species (Horiuchi and Aigaki, 
2006). However, given the constraints imposed by the 
transcription and splicing machineries, AS can result in 
anywhere from a single skipping event per gene to up to 
tens of thousands of potential splice variants per gene.
It has been inferred from the analyses of EST and AS 
microarray data that over two-thirds of human genes and 
over 40% of Drosophila genes contain one or more alter-
native exons (Johnson et al., 2003; Stolc et al., 2004). In 
sharp contrast to these estimates, S. cerevisiae has only 
several known regulated splicing events and lacks ortho-
logs for many factors associated with regulated splicing 
in metazoans, such as members of the serine/arginine-
repeat (SR) and heterogeneous nuclear ribonucleo-
protein (hnRNP) families of proteins (Davis et al., 2000; 
Boucher et al., 2001). The lack of sufficiently large data 
sets of AS microarray data and sequenced ESTs and 
cDNAs has prevented reliable estimates of the propor-
tions of genes that undergo AS in other organisms (Brett 
et al., 2002; Kim et al., 2004). There are also insufficient 
data currently available to accurately assess the overall 
number of AS events in any one organism. In the case of 
human genes known to undergo AS, based on available 
transcript sequence and microarray profiling data, it is 
estimated that there are between one and two AS events 
per multi-intron gene (Lander et al., 2001; Johnson et al., 
2003). However, this number may rise considerably as 
large-scale analyses of AS are performed in more spe-
cialized cell and tissue types. In addition, certain genes 
that undergo “extreme AS,” such as the Dscam gene in 
Drosophila, are clearly outliers that confound the deriva-
tion of accurate estimates for the overall frequency and 
complexity of AS. Nevertheless, the results of recent 
bioinformatic and microarray-based analyses have pro-
vided several interesting insights into the nature of the 
evolutionary forces that can impact overall AS frequen-
cies, as well as on additional global features of AS that 
will be discussed below.
Evolutionary Forces Acting on Global AS 
 Frequencies
Several recent studies have provided evidence that the 
number of AS events per gene is inversely correlated 
with gene or paralog copy number, indicating that gene 
duplication, followed by divergence of paralog functions, 
may have reduced selection pressure to diversify gene 
functions by AS (Kopelman et al., 2005; Su et al., 2006). 
Moreover, sequence- and microarray-based analyses 
have indicated that AS events occur more often in tran-
scripts from genes expressed in functionally complex 
tissues with diverse cell types, such as the brain and 
testis, or from genes expressed within individual cell 
types that have undergone selection to provide diverse 
functions, such as in the immune system (Modrek et al., Cell 126, July 14, 2006 ©2006 Elsevier Inc. 39
2001; Johnson et al., 2003; Yeo et al., 2004; Watson et 
al., 2005). Indeed, the number of documented examples 
of regulated AS in the brain is vast, and many of these 
events are implicated in complex processes such as 
the control of synaptic plasticity associated with cogni-
tion and other neural processes (Lipscombe, 2005; Ule 
and Darnell, 2006). One example of particular interest 
involves AS of the apolipoprotein E receptor (Apoer2) 
gene, which is important for neuronal cell migration dur-
ing brain development, as well as for long-term poten-
tiation (LTP) in adult mice. Deletion of a single, activity-
dependent alternative exon in the Apoer2 gene prevents 
tyrosine phosphorylation of NMDA receptor subunits 
by Reelin, a ligand of Apoer2 (Beffert et al., 2005). Mice 
missing this Apoer2 exon perform poorly in memory and 
learning tasks. Besides demonstrating a role for AS of 
Apoer2 transcripts in LTP, this study also serves to illus-
trate the importance of targeting individual alternative 
exons when attempting to understand the regulation of 
complex biological processes.
Which AS Events Are Functionally Significant?
Independent sources of experimental data from AS 
microarray profiling, RT-PCR assays, and analyses of 
EST and cDNA sequences have provided consistent evi-
dence that many alternatively spliced transcripts are low 
in abundance, especially those that are not conserved 
over the ?80 million year time interval separating human 
and mouse. In fact, comparisons of sequenced tran-
scripts corresponding to large numbers of ortholog gene 
pairs in human and mouse indicate that only 10%–20% 
of cassette-type AS events are conserved between these 
species (Modrek and Lee, 2003; Sorek et al., 2004; Pan 
et al., 2005; Yeo et al., 2005). The remaining 80%–90% 
of human- and mouse-specific cassette-type AS events 
can be separated into two categories: (1) those involv-
ing relatively recently gained “genome-specific” exons, 
which tend to be included at low levels in spliced mRNA 
(also referred to as “minor-form” variants) (Lev-Maor et 
al., 2003; Modrek and Lee, 2003), and (2) those involving 
exons that are conserved but alternatively spliced in only 
one species, which are generally skipped at low levels in 
spliced mRNA (Pan et al., 2004, 2005).
The sequences of exons and flanking intron regions of 
AS events present in human and mouse are on average 
significantly more conserved than those of both species-
specific AS and constitutive splicing events. Conserved 
AS events also more frequently preserve open reading 
frames (Philipps et al., 2004; Resch et al., 2004a; Sorek 
et al., 2004; Yeo et al., 2005) (see below). Remarkably, 
comparisons of nucleotide substitution rates in human 
and mouse indicate that, on average, as many as half of 
the synonymous positions in codons of conserved alter-
natively spliced exons are under selection pressure (Xing 
and Lee, 2005a). These and other interspecies compari-
sons support the conclusion that conserved alternative 
exons and their flanking introns are strongly enriched 
in splicing regulatory elements (Yeo et al., 2005) (see 40 Cell 126, July 14, 2006 ©2006 Elsevier Inc.below). Also consistent with this view, a recent analy-
sis of AS microarray data has revealed that conserved 
AS events undergo differential regulation between tis-
sues more often than AS events that are species specific 
(Xing and Lee, 2005b). Together, these observations 
suggest that species-specific splice variants, relative 
to conserved splice variants, may less frequently play 
important functional roles.
Surprisingly, over one-third of AS events identified in 
sequenced transcripts from human and mouse intro-
duce in-frame premature termination codons (PTCs), 
which have the potential to trigger transcript degra-
dation by the process of nonsense-mediated mRNA 
decay (NMD) (Lewis et al., 2003). Based on this obser-
vation and experimental studies providing evidence 
that some protein factors, including splicing factors 
that bind RNA, can autoregulate their levels by binding 
to their own pre-mRNA to promote increased levels of 
PTC-containing splice variants (Soergel et al., 2005), it 
had been speculated that AS-coupled NMD could pro-
vide a frequent mechanism for the regulation of gene 
expression (Lewis et al., 2003). However, more recent 
analyses have shown that most PTC-containing splice 
variants are not conserved between human and mouse 
(Baek and Green, 2005; Pan et al., 2006). Moreover, a 
recent microarray analysis of AS events in mammalian 
cells and tissues suggested that most PTC-containing 
splice variants are produced at low levels independent 
of the action of NMD and are rarely subject to tissue-
specific regulation (Pan et al., 2006). These results sup-
port the view that, although AS-coupled NMD may not 
play a widespread role in gene regulation, this process 
may serve to fine tune the levels of specific classes of 
factors, including subsets of splicing factors and other 
RNA binding proteins.
AS in Genome Evolution
The observations summarized above, in addition to other 
studies that have focused on comparisons of transcript 
diversity between species, reveal a fascinating aspect of 
AS that has undoubtedly had a major impact on genome 
evolution. The relatively high frequency of species-spe-
cific AS events that generate low-abundance splice 
variants provides a powerful “test bed” to evolve new 
or modified gene functions. The “minor” splice variants, 
which are found in low abundance, may not often have a 
major impact on physiology, whereas the more abundant 
splice variants are more likely to maintain critical gene 
activities. The minor splice variants therefore are rela-
tively unconstrained and may evolve more rapidly such 
that they either are lost or, over a longer evolutionary 
time span, are subject to positive selection if the splice 
variant confers a selective advantage. Consistent with 
this view, analyses of substitution rates in the genomes 
of different mammalian species indicate that the exons 
of species-specific splice variants evolve more rapidly 
than constitutive or conserved alternatively spliced 
exons (Xing and Lee, 2005a).
It is also interesting to consider the possibility that 
the accumulation of low-abundance splice variants pro-
duced from a large fraction of mammalian genes (as 
well as noncoding RNA transcribed from intronic and 
intergenic regions) could have a more subtle impact on 
physiology and perhaps indirectly influence species-
specific characteristics. For example, it is possible that 
many of these splice variants produce low levels of pro-
teins. Alternatively, these splice variants may sequester 
nucleic acid binding proteins, reducing their availability 
to function in the regulation of gene expression. In anal-
ogy to the latter situation, the expansion of CUG trinu-
cleotide repeats in the 3′UTR of the Dmpk gene, which is 
associated with myotonic dystrophy, is thought to result 
in the sequestration of the tissue-specific Muscleblind 
(MBNL) splicing factors, leading to aberrant AS patterns 
of disease-relevant genes (Kanadia et al., 2003). Cur-
rently, the extent to which the composition of the tran-
scriptome itself might indirectly influence AS or other 
steps in gene expression by sequestration of factors is 
not known.
AS Networks
A major goal of current and future AS research is to 
systematically elucidate the functional roles of physi-
ologically relevant AS events, as well as to establish 
how AS events are coordinated with other steps in gene 
expression to control specific cellular activities. Based 
largely on predictions from sequence analyses, only 
?10% of AS events have the potential to delete, insert, 
or modify functionally defined domains in proteins, and 
these events provide a relatively straightforward means 
to design appropriate experiments to address the func-
tional consequences of AS (Resch et al., 2004b; Pan et 
al., 2005). However, the remaining ?90% of AS events 
located in coding regions do not coincide with bound-
aries of functionally defined protein domains or regions 
that are obviously important for overall protein folding. 
Based on mapping of coding regions of alternative exons 
onto solved structures, it appears that most AS events 
affect coiled or “loop” regions of secondary structures, 
and the majority of these coding sequences are located 
on the surfaces of proteins (Wang et al., 2005). These 
regions are candidates for mediating protein-protein 
interactions or interactions with other types of ligands. 
Consistent with the possibility that AS has an important 
role in the formation and regulation of protein-protein 
interactions is the observation that, relative to tran-
scripts of multicopy genes, transcripts of single-copy 
genes more often undergo AS (Kopelman et al., 2005; 
Su et al., 2006) and also more often encode proteins 
that are found at highly connected nodes in interaction 
networks (Hughes and Friedman, 2005). These findings 
emphasize the importance of employing high-through-
put approaches to identify the interaction targets of spe-
cific coding regions specified by alternative exons and 
to integrate this information into existing knowledge of 
gene and protein interaction networks.The results of several recent microarray-based analy-
ses of AS are beginning to provide fascinating insights 
into how AS functions on a global level. Previous analyses 
using conventional microarrays revealed that groups of 
genes that are coregulated at the transcript level across 
different cell and tissue types, or under different growth 
conditions, tend to function in the same processes and 
pathways (Miki et al., 2001; Wu et al., 2002; Zhang et al., 
2004). Indeed, this property of transcriptionally coregu-
lated genes has been used to successfully predict the 
functions of unannotated genes (Wu et al., 2002; Zhang 
et al., 2004). Remarkably, sets of genes that are spe-
cifically regulated at the AS level in different cells and 
tissues do not extensively overlap with sets of genes 
regulated at the transcriptional level in the same cells 
and tissues (Le et al., 2004; Pan et al., 2004, 2006). This 
observation indicates that different subsets of genes 
may be coordinated at the levels of AS and transcription 
to regulate and maintain cell- and tissue-type-specific 
functions. However, the microarray data sets surveying 
AS in different cell and tissue types have not yet been 
sufficiently large to determine whether genes coregu-
lated at the level of AS are significantly associated with 
common functions, as observed for transcriptionally 
coregulated genes.
Nevertheless, previous studies on the Drosophila AS 
regulator Transformer-2 (Tra2), as well as a recent study 
employing AS microarray analyses of tissues from mice 
carrying a deletion in the gene for the brain-specific fac-
tor Nova-2, have indicated that at least some regulated 
AS events may be under coordinated control. Tra2 regu-
lates AS events that play an important role in control-
ling the function of two transcription factors, Doublesex 
and Fruitless, which regulate sets of genes involved in 
sex determination and courtship behavior, respectively 
(Forch and Valcarcel, 2003; Dulac, 2005). Genes con-
taining alternative exons that undergo a change in level 
in the brains of mice that lack Nova-2, compared to 
the brains of wild-type mice, are significantly enriched 
in Gene Ontology terms and manually curated annota-
tions associated with functions in the synapse and axon 
guidance (Ule et al., 2005). These results corroborated 
earlier findings by the same authors demonstrating that 
transcripts bound by Nova splicing factors in vivo also 
tend to be predominately associated with these neuro-
nal functions (Ule et al., 2003). Moreover, many of the 
protein products of the genes in the Nova-2-regulated 
group defined by the microarray analysis have been 
shown in earlier studies to physically interact (Ule et al., 
2005). Consistent with the earlier AS profiling studies, 
which indicated that the groups of genes that are regu-
lated by AS and transcription are primarily separate, the 
absence of Nova-2 did not appear to have a significant 
effect on the transcript levels of genes monitored on the 
AS microarray (Ule et al., 2005).
Further studies will be required to establish to what 
extent alternative exons in functionally associated genes 
are coordinated in the form of “exon networks” that Cell 126, July 14, 2006 ©2006 Elsevier Inc. 41
Figure 3. Elements of a “Splicing Code”
The diagram illustrates approximate relative distributions of splicing enhancer and silencer sequences in pre-mRNA in relation to constitutive, alter-
native, and pseudoexons, as well as to cryptic splice sites. Green arrows illustrate the positive activity of splicing enhancers (green bands) on the 
selection of adjacent splice sites in the alternative exon (blue box) and constitutive exons (yellow boxes). Pink arrows with flat heads indicate the 
negative activity of splicing silencers (pink bands) in pseudoexons and intronic regions proximal to cryptic splice sites, as well as in the alternative 
exon. The density of cryptic splice sites is underrepresented in the diagram for the sake of clarity.operate in parallel with networks of genes controlled at 
the level of transcription and other gene regulatory pro-
cesses. If this concept were found to apply on a wider 
scale, an important outcome would be the potential to 
predict the functions of thousands of currently unan-
notated genes on the basis of their correlated AS lev-
els. This might be especially useful in situations where 
such unannotated genes do not display significantly 
correlated patterns of expression at the transcript level. 
Moreover, the ability to further detect and characterize 
the functions of regulated AS events on a large scale 
will provide an entirely new perspective on how different 
cellular processes are regulated and communicate with 
one another. The development of siRNA screens for the 
functional characterization of splice variants, together 
with high-throughput “exon-resolution” protein-pro-
tein interaction screens, has considerable potential to 
uncover AS networks. Ultimately, a major goal will be to 
integrate this information into knowledge of coordinated 
gene-expression programs and networks that may be 
controlled at other levels in addition to transcription, 
including “mRNP operons” (i.e., functionally coordi-
nated sets of transcripts that are regulated at the levels 
of translation, stability, and export by RNA binding pro-
teins) (Keene and Lager, 2005), miRNA-mediated regu-
lation, and possibly other co-/posttranscriptional and 
translation-control mechanisms.
Defining a Sequence Code for Regulated AS
In contrast to genes in budding yeast, which contain 
relatively few (?200 total) and short introns that are 
defined by highly conserved core splicing signals, the 
average human gene contains 8 to 9 introns demarcated 
by core splicing signals that are generally poorly con-
served. These core signals lack sufficient information 
content for the splicing machinery to distinguish correct 
pairs of splice sites from cryptic splice sites, which are 
vastly more abundant than correct splice sites (Senap-
athy et al., 1990; Sun and Chasin, 2000). A combina-
tion of studies employing site-directed mutagenesis of 
pre-mRNA reporters, binding and functional SELEX of 
RNA binding splicing factors, and computational strat-
egies have resulted in the identification of additional 42 Cell 126, July 14, 2006 ©2006 Elsevier Inc.cis-acting sequence elements in exons and introns that 
are important for promoting splice-site recognition and 
discriminating correct from incorrect pairs of splice 
sites (Cartegni et al., 2002; Matlin et al., 2005) (Figure 
3). These sequences, referred to as exonic splicing 
enhancers/silencers (ESEs/ESSs) and intronic splicing 
enhancers/silencers (ISEs/ISSs), also play important 
roles in the regulation of AS. An important goal toward 
defining the functions of AS events is also to understand 
the mechanisms by which these cis-acting sequences 
in pre-mRNA combine with each other and with trans-
acting splicing factors to define global splicing patterns. 
The availability of extensive transcript sequence data 
and AS profiling technologies is beginning to yield new 
insights into the nature of this “splicing code.”
Previously detected enhancer and silencer sequences 
tend to be short (typically ?5–10 nt in length) and con-
sist of relatively degenerate consensus sequences that 
are recognized by the RNA binding domains of a diverse 
array of factors at the earliest stages of spliceosome 
formation (Matlin et al., 2005). These factors include 
members of the SR and hnRNP families of proteins, 
which can activate and repress the formation of interac-
tion networks across exons and introns that participate 
in spliceosome assembly (refer to Figure 4 for further 
information). The degenerate nature of enhancer and 
silencer elements probably reflects evolutionary selec-
tion pressure to provide flexible recognition by cognate 
RNA binding domains because the overlapping regions 
are often under selection pressure to maintain protein 
coding sequences.
Density distribution plots of ESE and ESS elements, 
as defined by both experimental and computational 
methods, have provided several surprising observa-
tions. In addition to being concentrated in pseudoexons 
and regulated alternative exons relative to constitutive 
exons, silencer motifs are also enriched in the intronic 
flanks proximal to constitutively spliced exons. This sug-
gests that these elements could perform an important 
role in the precise definition of constitutive splice sites, 
in addition to suppressing cryptic exons and regulating 
AS (Zhang and Chasin, 2004; Wang et al., 2004). More-
over, recent work has also shown that diverse silencer 
Figure 4. Regulation of Crossintron and 
Crossexon Interactions by SR and hnRNP 
Proteins
U1 and U2 small nuclear ribonucleoprotein 
particles (snRNPs) associate with the 5′ splice 
site and branch site, respectively. Binding of U2 
snRNP to the branch site is promoted by the 
binding of an alternating arginine/serine (RS) 
domain-containing factor (U2AF) to the polypy-
rimidine tract (PPT). Binding of other RS domain 
proteins, such as members of the SR family and 
SR-related proteins, to exonic splicing enhancer 
(ESE) motifs (green bands) within the alterna-
tive exon (blue box) also facilitates the stable 
assembly of U1 and U2 snRNPs. The large RS 
domain protein (green oval) represents an SR-
related splicing coactivator protein that serves 
to bridge crossintron, and possibly crossexon, 
interactions involving snRNPs and ESE bound 
SR proteins. 
(A) Model for RS domain proteins in mediating 
the ESE-dependent inclusion of the alternative 
exon. 
(B) Model for exonic splicing silencer (ESS) de-
pendent skipping of the alternative exon pro-
moted by the binding of an hnRNP protein to an 
ESS. Binding of the hnRNP protein to the ESS 
leads to its multimerization along the alternative 
exon, as mediated by the arginine/glycine (RG) 
repeat region of the protein. Multimerization of 
the hnRNP protein is proposed to disrupt the 
binding of one or more adjacent SR proteins, re-
sulting in exon skipping. Other proposed models 
for competition between SR and hnRNP proteins 
include a steric hindrance mechanism, in which the binding of an hnRNP protein to an ESS directly displaces an adjacent SR protein, and a “loop-
ing-out” mechanism, in which binding of hnRNP proteins to distal sites within the introns flanking an alternative exon result in preferential splicing 
of the distal splice sites and skipping of the alternative exon (Martinez-Contreras et al., 2006). These models are not mutually exclusive and may 
operate in different pre-mRNAs. Also not shown are interactions involving intronic splicing enhancers (ISE) and silencers (ISS), which can function 
to promote or repress interactions required for the inclusion of adjacent alternative exons (see Figure 3).sequences, as well as some ESEs, play an important 
role in controlling the selection of alternative 5′ and 3′ 
splice sites and that a specific class of silencers may 
also function to regulate intron retention events (Wang 
et al., 2006).
The combination of data on splice-site strength and 
the distributions of enhancer and silencer elements has 
helped formulate an initial “draft” splicing code that can 
simulate splice-site selection with considerable accuracy 
(Wang et al., 2004). However, what is currently missing 
from this draft is information allowing prediction of cell- 
and tissue-specific AS, as well as information allowing 
the accurate prediction of which protein factors are most 
likely to target which exons. Nevertheless, the applica-
tion of siRNA-mediated knockdowns and conventional 
knockouts of splicing factors, together with AS microar-
ray analyses, may provide the data sets required to at 
least partially bridge the current gap in information. For 
example, a microarray containing probes for all anno-
tated Drosophila splice variants was used to analyze 
splicing patterns in cultured Drosophila S2 cells follow-
ing the individual knockdown of four different proteins 
known to regulate AS, dASF/SF2, B52/SRp55, hrp48, 
and PSI (Blanchette et al., 2005). The number of AS 
events regulated by each factor was found to be highly 
variable, and some events were regulated by multiple 
factors. The consensus binding site for B52, a Drosophila SR protein defined in a previous in vitro selection assay, 
was found to be enriched in the exons regulated by this 
factor. Another AS microarray profiling study performed 
in mouse tissues revealed the existence of new motifs 
that are correlated with brain- and muscle-specific AS 
events (Sugnet et al., 2006). Interestingly, these motifs, 
as well as several other motifs correlated with brain- and 
muscle-specific AS as revealed by sequence-based 
analyses, appear to consistently reside in the intron 
regions proximal to regulated alternative exons (Brudno 
et al., 2001; Minovitsky et al., 2005; Sugnet et al., 2006). 
Clearly, an important goal of future studies will be to 
further define cell- and tissue-specific splicing regula-
tory motifs and how they function in conjunction with 
each other as well as with the more generally utilized 
enhancer and silencer motifs. Ultimately, such studies 
should facilitate formulating an expanded splicing code 
that will allow the prediction of cell- and tissue-specific 
splicing patterns.
Regulation of Splicing and Human Disease
An important outcome of many of the recent global anal-
yses of splicing is our increased understanding of the 
role of splicing defects in human disease. Significantly, a 
more detailed knowledge of the identity and distribution 
of splicing enhancer and silencer sequences in exons 
and introns has already provided valuable information Cell 126, July 14, 2006 ©2006 Elsevier Inc. 43
for improving our ability to predict which disease muta-
tions have the potential to disrupt splicing (Cartegni et 
al., 2002; Fairbrother et al., 2002; Pagani and Baralle, 
2004; Wang et al., 2004; Zhang and Chasin, 2004). This 
is important because many disease mutations that tar-
get nonsynonymous amino acid codon positions are 
often assumed to cause disease through changes to 
the amino acid sequence of a protein, whereas careful 
examination of transcripts from many disease genes is 
revealing that many such mutations can cause more seri-
ous defects by disrupting the inclusion of an entire exon 
or activation of a cryptic splice site. Either event has the 
potential to introduce a PTC resulting in degradation 
of the entire transcript by NMD (Cartegni et al., 2002; 
Pagani and Baralle, 2004). Likewise, many disease-
associated mutations that target synonymous codon 
positions affect splicing. Examples of human disease 
genes known to be targeted by synonymous and non-
synonymous mutations that often affect exonic splicing 
control elements include BRCA1 (breast cancer 1, early 
onset), CFTR (cystic fibrosis transmembrane conduc-
tance regulator), HPRT1 (hypoxanthine phosphoribos-
yltransferase 1), MAPT (microtubule-associated protein 
tau), and SMN1 (survival of motor neuron 1) (Cartegni et 
al., 2002). Such studies, as well as data stemming from 
several different types of analyses, including nucleotide 
substitution rates in the orthologous exons of different 
species, surveys of the complexity and distributions of 
ESE and ISE sequences, and more systematic analyses 
of transcripts from specific disease genes such as NF1 
(neurofibromatosis type 1) and ATM (ataxia telangiec-
tasia mutated) (Teraoka et al., 1999; Ars et al., 2000), 
lead to the striking conclusion that as many as 50% of 
disease mutations in exons may impact on splicing. This 
Figure 5. Layers of Coordinated Gene Regulation
Recent microarray-based studies have provided evidence that differ-
ent subsets of genes are regulated at the levels of transcription and 
AS to define cell- and tissue-type-specific gene-expression profiles. 
An emerging model is that these subsets of genes may comprise “lay-
ers” of gene networks that coordinate specific cellular functions. The 
dotted lines indicate hypothetical interconnections that serve to inte-
grate these and the other layers of gene regulation shown.44 Cell 126, July 14, 2006 ©2006 Elsevier Inc.conclusion strongly attests to the importance of intro-
ducing routine transcript analyses in order to properly 
assess possible mechanisms accounting for human 
diseases. Moreover, the high degree of conservation 
of intron sequences flanking conserved AS events indi-
cates that these regions in disease genes should also be 
routinely examined for mutations that alter splicing.
Microarray profiling technologies present major pos-
sibilities for the future transformation of clinical practice 
because gene-expression signatures can provide valu-
able diagnostic and prognostic information, which in 
turn facilitates choices for appropriate treatments. The 
recent advent of AS microarrays and the resulting data 
indicate that it will be important to obtain AS signatures 
because profiling at the transcript level, or at other lev-
els of gene expression, may entirely miss important dis-
ease-relevant changes in gene expression at the level 
of splicing. Indeed, given the recent evidence summa-
rized above for the increased role of disease mutations 
in splicing, it is quite possible that microarrays enabling 
profiling of splicing may in many cases provide more 
informative diagnostic or prognostic signatures than can 
be obtained from conventional microarrays for profiling 
levels of gene expression. In support of this view, a very 
recent analysis of microarray data from profiling both 
AS and transcript levels in prostate tissues revealed 
that detection of splice variants can permit a more reli-
able discrimination of tumor from normal tissue than the 
detection of transcript-level differences in the same tis-
sue samples (Li et al., 2006; Zhang et al., 2006).
Conclusions and Future Directions
Initial computational analyses of transcript sequences 
and microarray profiling of splicing have provided a more 
detailed understanding of the extent and complexity of 
AS in different cells and tissues. However, the ques-
tion remains as to whether we are just observing the 
tip of the iceberg or whether the majority of important 
AS events have already been identified. A satisfactory 
answer to this question will require more extensive exon 
coverage by both sequencing and AS profiling strate-
gies in a wider range of cells and tissues, including those 
that are less abundant and/or more specialized. Also 
important will be an expansion of the application and 
sensitivity of high-throughput methods, such as mass 
spectrometry and antibody microarrays, to detect splice 
variants at the protein level. Moreover, the range of spe-
cies examined by these AS profiling methods needs to 
be expanded. For example, due to the lack of substantial 
transcript sequence data, we currently know very little 
about how splicing patterns compare in the chimpanzee, 
our closest primate relative. Yet as a major step in gene 
regulation, we can anticipate that differences in AS, like 
transcription, may play an important role in accounting 
for primate-species-specific characteristics.
Another important outcome of recent studies on AS is 
the finding that the majority of genes regulated in a tis-
sue-specific manner by AS are different from those reg-
ulated in a tissue-specific manner at the transcriptional 
level. Moreover, it is emerging that groups of tissue-spe-
cific AS events may function in a coordinated manner in 
specific pathways or interaction networks, in much the 
same way as has been observed for groups of genes 
coregulated at the transcriptional level. This promotes 
the concept of “layers” of gene regulation and raises 
the interesting question as to the extent and nature of 
exon networks that may serve in parallel with other lay-
ers to coordinate gene activities and interactions so as 
to refine and/or expand cell- and tissue-type-specific 
functions (Figure 5). Other parallel layers of regulation 
that presumably also occur on a frequent basis include 
miRNA- and non-miRNA-mediated control of mRNA 
turnover or translation, mRNA localization, as well as 
other posttranscriptional and co-/posttranslational 
mechanisms. An important goal in the future will be to 
understand how these layers of regulation are integrated 
with one another. Clearly, understanding gene-expres-
sion regulation at an exon-level resolution will be a major 
goal of future research in what may well be defined as 
the “exonomics” era.
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